Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2017PLoS ONEOpen Access

Ascofuranone inhibits lipopolysaccharide–induced inflammatory response via NF-kappaB and AP-1, p-ERK, TNF-α, IL-6 and IL-1β in RAW 264.7 macrophages

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJun‐Young ParkKorea Research Institute of Bioscience and BiotechnologyTCTae‐Wook ChungPusan National University HospitalYJYun‐Jeong JeongEwha Womans University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2017) studied this question.

synapsesocial.com/papers/6a71eb756ceb2bbd16e041d7https://doi.org/10.1371/journal.pone.0171322
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Transcriptional Roles of Nuclear Factor κB and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor α-Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 Cells1995 · 654 citations
  2. 2ISOLATION AND STRUCTURE OF ASCOFURANONE AND ASCOFRANOL, ANTIBIOTICS WITH HYPOLIPIDEMIC ACTIVITY1973 · 84 citations
  3. 3Blocking NF-κB: An Inflammatory Issue2011 · 198 citations
  4. 4Anti-Inflammatory Activities of Inotilone from Phellinus linteus through the Inhibition of MMP-9, NF-κB, and MAPK Activation In Vitro and In Vivo2012 · 102 citations
  5. 5Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes.1988 · 48 citations